ROHTO PHARMACEUTICAL CO.,LTD.

Transcripts Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Delayed Japan Exchange Other stock markets 12:12:37 2024-04-30 am EDT			5-day change	1st Jan Change
3,048 ^JPY	+0.40%		+2.35%	+7.39%

Apr. 04	Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen	MT
Apr. 04	Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update	DJ

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rohto Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-05-20	CI
Rohto Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022	22-02-17	CI
Rohto Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022	21-11-18	CI
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	21-08-18	CI
Rohto Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022	21-05-21	CI
Rohto Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021	21-02-17	CI
Rohto Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2021	20-11-18	CI
Rohto Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021	20-08-10	CI
Rohto Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021	20-05-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer